Please login to the form below

Not currently logged in
Email:
Password:

brain cancer

This page shows the latest brain cancer news and features for those working in and with pharma, biotech and healthcare.

AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain

AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain

AstraZeneca’s Tagrisso cuts the risk of EGFR-positive lung cancer patients developing brain metastases, according to new data revealed by the company on Saturday. ... According to AZ, CNS recurrence – in which the cancer spreads to the brain – is

Latest news

More from news
Approximately 1 fully matching, plus 78 partially matching documents found.

Latest Intelligence

  • Cancer care – the power of new technologies Cancer care – the power of new technologies

    on the tumour type that they had, with brain cancer patients highlighting a significantly worse experience than for other tumour types. ... As people are living longer, more and more people will be living longer with cancer.

  • Deal Watch January 2018

    enhance blood-brain barrier (BBB) penetration of antibody molecules via the transferrin receptor. ... that is highly selective for HER2.  Tucatinib is currently being evaluated in a phase II pivotal trial in patients with HER2-positive metastatic

  • Sharing ideas to improve care for cancer patients – part 2 Sharing ideas to improve care for cancer patients – part 2

    Taking place on September, 4 at 1pm, the free, one-hour webinar will feature speakers from Bristol Testicular Cancer Service, Mount Vernon Cancer Centre and The Brain Tumour Charity. ... Theresa Sullivan, Macmillan Patient Information Lead, Mount Vernon

  • Sharing ideas to improve care for cancer patients – part 1 Sharing ideas to improve care for cancer patients – part 1

    from Bristol Testicular Cancer Service, Mount Vernon Cancer Centre and The Brain Tumour Charity. ... Title: Shout Out! magazine for 7-13 year olds with living with cancer.

  • Interview: Michel Goldman, Innovative Medicines Initiative Interview: Michel Goldman, Innovative Medicines Initiative

    And we do this by implementing proposals in different areas. For example, we have several projects on brain disorders, diabetes, cancer, inflammatory disorders and several projects on pulmonary diseases, to give

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics